Weekly healthcare intelligenceRegulation · Enforcement · Government payersAll editions →

Medicare & Medicaid Sweep · November 15, 2026

The leading stories for your work. Choose a topic to focus the front page.

Published November 15, 2026 · Reporting window November 8–14, 2026, Pacific. Later developments are labelled. Source coverage is incomplete; the complete reports describe the limitations.

Showing 15 of 24 articles and reminders.

Illustrative artwork
Billing & paymentMedicare & Medicaid SweepUpdated

CMS issues contractor instructions for the CY 2027 ESRD PPS: low-volume adjustment tiers and December 31, 2026 attestation deadline

On November 12, 2026 CMS issued Transmittal R14043BP (Change Request 14638), the annual update that implements the calendar year (CY) 2027 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) rate updates and policies for Medicare contractors, effective January 1, 2027 with implementation January 4, 2027. It states the CY 2027 base rate of $297.52, expands the low-volume payment adjustment (LVPA) to facilities furnishing fewer than 8,000 treatments in each of the past three cost-reporting years, in six tiers, and extends the LVPA attestation deadline to December 31, 2026: facilities must attest by that date to receive the adjustment for payment year 2027, unless extraordinary circumstances justify an exception. It directs Medicare contractors to extend the attestation deadline for payment year 2027 to December 31, 2026. A companion systems transmittal, R13909CP (Change Request 14551), dated August 7, 2026, was re-communicated on November 13, 2026, with a note that it may now be posted publicly; the CMS transmittals index lists it with an issue date of November 12, 2026. On November 15, 2026 the Federal Register record for the rule still gave an effective date of January 1, 2027 and listed no corrections.

High priority · Nov 15, 2026 editionRead story →

Illustrative artwork
Billing & paymentMedicare & Medicaid SweepConditional reminder

CMS issues CY 2027 Physician Fee Schedule final rule (CMS-1848-F): conversion factors fall, same-day E/M and 0-day global payment cut, new 340B Part D claims repository duty

CMS finalized the calendar year (CY) 2027 Physician Fee Schedule (PFS) rule, CMS-1848-F, published November 9, 2026 and effective January 1, 2027. It lowers both conversion factors, cuts payment when an office or outpatient evaluation and management (E/M) visit is furnished on the same day as a 0-day global procedure by the same physician or a physician in the same practice (the condition as CMS proposed it), and requires 340B covered entities to submit claim data to a CMS repository for units of covered Part D drugs dispensed by the entity or its contractors for which a manufacturer provides a 340B discount, for dates of service from January 1, 2027, with the first quarterly submission due September 30, 2027.

High priority · Nov 15, 2026 editionRead story →

Illustrative artwork
Medi-Cal & Medicaid policyMedicare & Medicaid SweepConditional reminder

Medi-Cal youth gender-affirming services (APL 26-018): federal reimbursement limit from October 13, 2026 and hormone transition through April 12, 2027

Department of Health Care Services (DHCS) All Plan Letter (APL) 26-018, Federal Reimbursement Limitation on Gender-Affirming Care Services for Youth, is listed in the DHCS letter index with the date 09/30/2026. As the October 11 article reported it, the letter limits reimbursement from October 13 for specified gender-affirming surgery, puberty blockers and hormone therapy for Medi-Cal members under 18 and Children's Health Insurance Program (CHIP) members under 19 (services for other medical indications and treatment of complications remain covered when medically necessary), keeps a transition through April 12, 2027 for hormones already being taken as of October 13 (for affected plan members, only under the medical benefit), and requires plans to submit policies, an attestation and copies within 90 calendar days of release, which the article gave as December 29.

High priority · Nov 15, 2026 editionRead story →

Illustrative artwork
Medi-Cal & Medicaid policyMedicare & Medicaid SweepConditional reminder

DHCS notice (October 9): Medi-Cal clinic institutional claims submitted from October 15 require diagnosis codes

In a notice published October 9, 2026, the Department of Health Care Services (DHCS) said that for all Medi-Cal claims submitted on or after October 15, 2026, at least one clinically appropriate International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code is required on a UB-04 claim form or the 837I electronic form by Federally Qualified Health Centers (FQHCs), Rural Health Clinics (RHCs), Indian Health Services (IHS) Memorandum of Agreement (MOA) 638 providers and Tribal FQHCs. The trigger is the claim submission date, not a new date-of-service limit, and the notice says updated provider manual sections will be released in a future Medi-Cal Update. First reported in the October 11 edition.

High priority · Nov 15, 2026 editionRead story →

Illustrative artwork
Billing & paymentMedicare & Medicaid SweepConditional reminder

Medicare to pay ASP minus 28 percent, or another set basis where ASP is unavailable, for separately payable 340B-acquired drugs at non-exempt hospitals from January 1, 2027 (pass-through drugs, vaccines and non-opioid pain relief drugs excluded); every separately paid OPPS drug line must carry modifier JG, TB or ND

In the CY 2027 Hospital Outpatient Prospective Payment System (OPPS) final rule, published November 6, 2026, CMS will pay average sales price (ASP) minus 28 percent for separately payable drugs acquired under the 340B Program at non-exempt hospitals from January 1, 2027 when ASP is available; where ASP is not available, payment is based on wholesale acquisition cost (WAC) minus 28 percent, then 64.53 percent of average wholesale price (AWP), then 100 percent of mean unit cost (MUC), then the invoice price, and certain products such as nonpass-through diagnostic radiopharmaceuticals with claims data continue to be paid on arithmetic MUC; pass-through drugs, vaccines and non-opioid pain relief drugs are excluded, and rural sole community hospitals (SCHs), children's hospitals and cancer hospitals exempt from the prospective payment system (PPS) are exempt. From the same date every separately paid OPPS drug claim line, billed under its Healthcare Common Procedure Coding System (HCPCS) code, must carry modifier JG, TB or ND.

High priority · Nov 15, 2026 editionRead story →

More in this edition

Read all 24 articles and reminders →

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies